待处理
入排:排除
图源:待检查
Reply to Letter to the Editor: 'ALBAN (GETUG-AFU 37): a phase 3, randomized, open-label, international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle invasive bladder cancer (NMIBC)' by R. Contieri et al.
M Rouprêt
Ann Oncol 37(5) 749-750
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板